C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2001
11/29/2001	WO2001090197A1 Synthetic peptides and uses therefore
11/29/2001	WO2001090194A2 Antibodies against particular forms of propsa and use thereof in immunoassays
11/29/2001	WO2001090192A2 Bispecific immunoglobulin-like antigen binding proteins and method of production
11/29/2001	WO2001090191A2 ANTIBODIES CAPABLE TO SELECTIVELY DETECT PRION PrPSc ISOFORMS
11/29/2001	WO2001090190A2 Single-domain antigen-binding antibody fragments derived from llama antibodies
11/29/2001	WO2001090189A2 G-protein coupled receptor org3.
11/29/2001	WO2001090188A2 Receptor-based interaction trap
11/29/2001	WO2001090187A2 G-protein coupled olfactory receptors
11/29/2001	WO2001090185A2 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
11/29/2001	WO2001090184A1 A novel polypeptide, a growth hormone 11 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090183A2 Human secreted protein, zsig47
11/29/2001	WO2001090179A2 Novel human thrombospondin-like proteins and polynucleotides encoding the same
11/29/2001	WO2001090177A1 A novel polypeptide, a human natural killer cell enhancing factor b13.64 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090176A1 A novel polypeptide - human keratin 45.87 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090175A1 A novel polypeptide, a molecular chaperone cpn60 protein 15 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090174A1 A novel polypeptide-human peroxisome fatty acid acetyl-coa oxidase 46.97 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090173A1 A novel polypeptide, a molecular chaperone cpn60 protein 10 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090172A1 A novel polypeptide-human ribosomal l39 protein 13 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090171A1 A novel polypeptide-human robosomal sii protein 12 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090170A1 A novel polypeptide, a human neural cell adhesion protein 31 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090169A1 A novel polypeptide- human proliferating cell nuclear antigen (pcna) 13 and the polynucleotide encoding said polypeptide
11/29/2001	WO2001090168A1 A novel polypeptide, a human atp dependent-uncoiling enzyme protein 10 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090167A1 A novel polypeptide, a human zinc finger protein 11 and the polynucleotide encoding the polypeptide
11/29/2001	WO2001090166A1 A novel polypeptide-homo thyroglobulin 11 and polynucleotide encoding said polypeptide
11/29/2001	WO2001090165A1 A novel polypeptide-homo laminin protein b2 chain 13 and polynucleotide encoding said polypeptide
11/29/2001	WO2001090160A2 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE
11/29/2001	WO2001090159A2 Compositions and methods for delivery of a molecule into a cell
11/29/2001	WO2001090158A1 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090155A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/29/2001	WO2001090154A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
11/29/2001	WO2001090152A2 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001	WO2001090151A2 Human receptor proteins; related reagents and methods
11/29/2001	WO2001090149A2 G protein-coupled receptors
11/29/2001	WO2001090148A2 Neurotransmitter transporters
11/29/2001	WO2001090147A2 Long wavelength engineered fluorescent proteins
11/29/2001	WO2001090146A2 57256 and 58289, human transporters and uses thereof
11/29/2001	WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
11/29/2001	WO2001090142A2 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS
11/29/2001	WO2001090139A2 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001	WO2001090135A1 Drug-amino acids sequence chimeric molecules
11/29/2001	WO2001090133A1 A novel peptide - human uracil-dna glycosylase 22 and the polynucleotide coding this novel peptide
11/29/2001	WO2001089729A2 Compositions and methods for microbial dechlorination of polychlorinated biphenyl compounds
11/29/2001	WO2001089705A2 System and method for manipulating magnetically responsive particles in fluid samples to collect dna or rna from a sample
11/29/2001	WO2001089593A1 Transfection system
11/29/2001	WO2001089583A2 Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases
11/29/2001	WO2001089581A1 Medicinal compositions containing prostacyclin synthase gene
11/29/2001	WO2001089568A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001	WO2001089559A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	WO2001089556A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
11/29/2001	WO2001089550A2 Use of ciliary neurotrophic factor
11/29/2001	WO2001089535A1 Method for introducing and expressing genes in animal cells, and bacterial blebs for use in same
11/29/2001	WO2001089364A2 Hcv variants
11/29/2001	WO2001089361A2 Diagnosis, prevention and treatment of crohn's disease using the ompc antigen
11/29/2001	WO2001089304A1 Method of producing herpes simplex virus amplicons, resulting amplicons, and their use
11/29/2001	WO2001089303A1 Methods of modulating the activity of mura
11/29/2001	WO2001089283A1 Protein translocation into plant cells
11/29/2001	WO2001062284A3 Novel method for down-regulation of amyloid
11/29/2001	WO2001060854A8 Novel members of the h+/oligopeptide transporter gene family
11/29/2001	WO2001058935A3 FACTOR VII OR VIIa-LIKE MOLECULES
11/29/2001	WO2001055173A8 Nucleic acids, proteins, and antibodies
11/29/2001	WO2001046694A3 A bioluminescence resonance energy transfer (bret) fusion molecule and method of use
11/29/2001	WO2001044465A3 Therapeutically useful synthetic oligonucleotides
11/29/2001	WO2001044458A3 Bovine immunodeficiency virus (biv) based vectors
11/29/2001	WO2001044280A3 Methods and compositions for the manufacture of replication incompetent adenovirus
11/29/2001	WO2001043869A3 Cell arrays and the uses thereof
11/29/2001	WO2001042471A8 Polypeptides and polynucleotides encoding same
11/29/2001	WO2001042454A3 Methods for detecting compound interactions using phage display
11/29/2001	WO2001042447A3 Modified minimal promoters
11/29/2001	WO2001042446A3 A functional gene array in yeast
11/29/2001	WO2001042445A3 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS
11/29/2001	WO2001042283A3 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation
11/29/2001	WO2001041557A3 Embryogenesis and plant regeneration from microspores
11/29/2001	WO2001040491A3 Udp-glucose:aglycon-glucosyltransferase
11/29/2001	WO2001040451A3 Masp-3, a complement-fixing enzyme, and uses for it
11/29/2001	WO2001040309A3 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use
11/29/2001	WO2001040257A3 Modified il-12 subunits and nucleic acids encoding them
11/29/2001	WO2001038566A3 Screening method for candidate drugs
11/29/2001	WO2001036644A3 Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
11/29/2001	WO2001034823A3 Method for enhancing resistance in plants
11/29/2001	WO2001034806A3 Methods and compositions for screening using diphtheria toxin constructs
11/29/2001	WO2001032886A3 Starch branching enzymes
11/29/2001	WO2001031025A3 Formylglycinamidinribotide synthase from plants
11/29/2001	WO2001031007A3 Nucleic acid molecules derived from rat brain and programmed cell death models
11/29/2001	WO2001030980A3 Methods and compositions for enhancing developmental potential of oocytes and zygotes
11/29/2001	WO2001029264A3 Nucleic acid primers and probes for detecting tumor cells
11/29/2001	WO2001029241A3 Methods and vectors for site-specific recombination in plant cell plastids
11/29/2001	WO2001029237A3 Conditional sterility in wheat
11/29/2001	WO2001029234A3 Self-cleaving rna sequences and their use for the control of protein synthesis
11/29/2001	WO2001028684A3 System and method for filling a substrate with a liquid sample
11/29/2001	WO2001027304A3 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001023590A3 22196, a novel human aminopeptidase
11/29/2001	WO2001023560A3 Isolated peptides which bind to mhc class ii molecules, and uses thereof
11/29/2001	WO2001020029A3 Genetic markers of toxicity, preparation and uses thereof
11/29/2001	WO2001016318A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/29/2001	WO2001014546A3 Replication protein a binding transcriptional factor (rbt1) and uses thereof
11/29/2001	WO2001000864A3 Nucleic acid binding of multi-zinc finger transcription factors
11/29/2001	WO2001000846A3 Linoleate isomerase
11/29/2001	WO2001000826A3 Novel molecules of the card-related protein family and uses thereof

1 ... 2932 2933 2934 2935 2936 2937 2938 2939 2940 2941 2942 2943 2944 2945 2946 2947 2948 2949 2950 2951 2952 ... 4023